ITPR2 and metabolic dysfunction-associated steatotic liver disease: Although the potential molecular mechanism of ITPR2 involved in the development of NAFLD remains unclear, it is reasonable to speculate that ITPR2 contributes to abnormal hepatocyte apoptosis in the liver of patients with NAFLD.